Company / Gross Profit
IGC Pharma, Inc. Gross Profit History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$619.0K
FY2025
5-year range
$113.0K / $619.0K
FY2021-FY2025
Trend
+40.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit has increased for 3 consecutive years, from $113,000 in FY2022 to $619,000 in FY2025.
Based on SEC 10-K filings.
$619,000 in FY2025 with a 5-year CAGR of +36.2%.
Improved from $194,000 to $619,000 over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +76.3%
- 5-Year CAGR
- +36.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- IGC Pharma, Inc.'s gross profit has grown for 3 consecutive years.
- 5-year CAGR of +36.2%, indicating consistent growth.
- In FY2025, gross profit increased 40.0% year-over-year.
- Lowest gross profit in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -13.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $619.0K | +40.0% |
| FY2024 | $442.0K | +127.8% |
| FY2023 | $194.0K | +71.7% |
| FY2022 | $113.0K | -1.7% |
| FY2021 | $115.0K | -12.9% |
| FY2020 | $132.0K | +61.0% |
| FY2019 | $82.0K | -62.4% |
| FY2018 | $218.2K | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026